Login | Forgot password? | Register | MyCME | Point of Care | All CME Activities | E-Lerts | Blog | About Us | Contact Us | Help | visit us on FacebookFacebook
Psychlopedia Main Page

Major Depressive Disorder [ CME Expired ]

These activities are part of the Depression Unit, which is supported by educational grants from Eli Lilly and Company and Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (registered users); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry(registered users)

CME Supplements from The Journal of Clinical Psychiatry (registered users)

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (paid subscribers)

PDFs of the full text of The Primary Care Companion, 1999–present

Diagnostic Assessment of Major Depressive Disorder

George I. Papakostas, MD

Certain demographic factors increase the risk of nonresponse or nonremission with an antidepressant. Find out about the prevalence of depression and its common comorbidities, and learn how to systematically evaluate MDD in your patients, including assessing aspects that may affect treatment response.

1 Credit    [See the entire activity]

 

Initial Treatment Approaches for Patients With Major Depressive Disorder

George I. Papakostas, MD

Do newer agents have better efficacy than SSRIs for treating specific depressive subtypes or symptom clusters? Review the efficacy, tolerability, and safety of antidepressants for MDD to determine the most appropriate agents for your patients.

1 Credit    [See the entire activity]

 

Beyond Acute Treatment of Depressive Disorders

Mark Hyman Rapaport, MD

Patients who remain on medication treatment after the acute phase have low rates of recurrence. Understand the necessity of continuation and maintenance therapy when treating patients with depression, and learn how to increase their likelihood of positive long-term outcomes.

1 Credit    [See the entire activity]

 

Helping Patients With Depression Achieve Wellness

Mark Hyman Rapaport, MD

Incomplete recovery from depression is associated with early relapse and likely recurrence. Find out how implementing measurement-based care can help you choose interventions that facilitate the ideal treatment outcome for patients with depression—wellness.

1 Credit    [See the entire activity]

 

Diagnosis and Treatment of a Major Depressive Episode

Michael E. Thase, MD

Are your patients with depression receiving the highest quality of care and achieving long-term symptomatic remission? In this interactive case, evaluate Ms. A, who is in a major depressive episode, and learn about treatment strategies to optimize your patients' overall outcome.

1 Credit    [See the entire activity]

 
George I Papakostas, MD
Harvard Medical School and Massachusetts General Hospital, Boston
Michael E. Thase, MD
University of Pennsylvania School of Medicine, Philadelphia Veterans Affairs Medical Center, and Pittsburgh Medical Center, Philadelphia and Pittsburgh
Mark Hyman Rapaport, MD
Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California, Los Angeles